Product
Standard of care treatment
3 clinical trials
4 indications
Indication
COVID-19Indication
Rheumatic Heart Disease in ChildrenIndication
Esophageal NeoplasmsIndication
NSCLCClinical trial
A Comparative Randomized Clinical Study on Covid-19 Positive Hospitalized Patients Supplemented With NASAFYTOLStatus: Completed, Estimated PCD: 2021-10-29
Clinical trial
Open-label, Randomized Controlled Trial to Assess Efficacy and Safety of Rituximab in Patients With Acute Rheumatic Fever in AfricaStatus: , Estimated PCD: 2024-09-30